NEW YORK (GenomeWeb) – Mars Petcare said this week that it has acquired OptiGen, a DNA diagnostics company specializing in canine inherited disorders, for an undisclosed amount. Included in the acquisition are exclusive licenses to a portfolio of genetic disease tests patented in the US, Australia, and many countries in Europe, and an extensive biobank of more than 150,000 samples collected over 20 years representing various canine eye diseases. Moving forward these samples will be used to discover new genetic health markers for dogs, Mars Petcare said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.